BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 21737886)

  • 1. Pancreatic neoplasm in 2011: an update.
    Saif MW
    JOP; 2011 Jul; 12(4):316-21. PubMed ID: 21737886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancements in the management of pancreatic cancer: 2013.
    Saif MW
    JOP; 2013 Mar; 14(2):112-8. PubMed ID: 23474549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-line treatment of metastatic pancreatic adenocarcinoma: can we do better? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Merl MY; Abdelghany O; Li J; Saif MW
    JOP; 2010 Jul; 11(4):317-20. PubMed ID: 20601801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second line therapy for advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Brus C; Saif MW
    JOP; 2010 Jul; 11(4):321-3. PubMed ID: 20601802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Up-to-date diagnosis and treatment of advanced pancreatic cancer].
    Stieler JM; Oettle H
    Dtsch Med Wochenschr; 2005 Sep; 130(38):2146-8. PubMed ID: 16172956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From targets to treatments: a review of molecular targets in pancreatic neuroendocrine tumors.
    Wiedenmann B; Pavel M; Kos-Kudla B
    Neuroendocrinology; 2011; 94(3):177-90. PubMed ID: 21893937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Everolimus in the treatment of renal cell carcinoma and neuroendocrine tumors.
    Chan HY; Grossman AB; Bukowski RM
    Adv Ther; 2010 Aug; 27(8):495-511. PubMed ID: 20623346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locally advanced pancreatic adenocarcinoma: are we making progress?. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Li J; Ng J; Allendorf J; Saif MW
    JOP; 2011 Jul; 12(4):347-50. PubMed ID: 21737893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of failure following surgical resection for malignant pleural mesothelioma.
    Jänne PA; Baldini EH
    Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant therapy of pancreatic cancer.
    Hilbig A; Oettle H
    Expert Rev Anticancer Ther; 2010 Apr; 10(4):485-91. PubMed ID: 20397913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updates on first-line treatment of metastatic pancreatic adenocarcinoma. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Strimpakos AS; Syrigos KN; Saif MW
    JOP; 2011 Jul; 12(4):339-42. PubMed ID: 21737891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updates in pancreatic neuroendocrine carcinoma. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Alsamarai S; Libutti SK; Saif MW
    JOP; 2010 Jul; 11(4):336-40. PubMed ID: 20601807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of non-small cell lung cancer: current perspectives and controversies, future directions.
    Bunn PA
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):49-59. PubMed ID: 8052874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pancreatic carcinoma].
    Böhmig M; Rosewicz S
    Z Gastroenterol; 2004 Mar; 42(3):261-8. PubMed ID: 15022114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial.
    Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH
    Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current medical treatment of pancreatic neuroendocrine tumors.
    Yalcin S; Oyan B; Bayraktar Y
    Hepatogastroenterology; 2007; 54(73):278-84. PubMed ID: 17419276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant Therapy of Pancreatic Cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Sharma C; Horowitz D; Chabot J; Saif MW
    JOP; 2011 Jul; 12(4):343-6. PubMed ID: 21737892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel agents in the treatment of unresectable neuroendocrine tumors. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Oberstein PE; Saif MW
    JOP; 2011 Jul; 12(4):358-61. PubMed ID: 21737896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.